Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start?

about

Diagnosis and treatment of non-hemodynamically significant coronary heart disease: where to start?

Item

http://www.wikidata.org/entity/Q28768666

description

2005 nî lūn-bûn

@nan

2005 թուականին հրատարակուած գիտական յօդուած

@hyw

2005 թվականին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Diagnosis and treatment of non ...... heart disease: where to start?

@ast

Diagnosis and treatment of non ...... heart disease: where to start?

@en

type

Item

label

Diagnosis and treatment of non ...... heart disease: where to start?

@ast

Diagnosis and treatment of non ...... heart disease: where to start?

@en

prefLabel

Diagnosis and treatment of non ...... heart disease: where to start?

@ast

Diagnosis and treatment of non ...... heart disease: where to start?

@en

P1476

Diagnosis and treatment of non ...... heart disease: where to start?

@en

P2093

George A Stouffer

http://www.w3.org/2001/XMLSchema#string

Marschall S Runge

http://www.w3.org/2001/XMLSchema#string

Natrajan Subramanian

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation of MEF2A in an inherited disorder with features of coronary artery disease

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Angiographic progression of coronary artery disease and the development of myocardial infarction.

Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology.

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.

P304

273-80; discussion 281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16555620

http://www.w3.org/2001/XMLSchema#string

P921

hemodynamics

P932

1473145

http://www.w3.org/2001/XMLSchema#string